---
$id: https://graph.org.ai/products/commodity/51281622
$type: Product
source: UNSPSC
code: "51281622"
title: "Ribostamycin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ribostamycin

**UNSPSC Code**: 51281622
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Q5JOU7T53. European Medicines Agency schedules Ribostamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10300MIG. Ribostamycin generally arises in the molecular formula C17H34N4O10. The term RIBOSTAMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, no. 10 1972, list 12.) RIBOSTAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ribostamycin under HS 29419000 and SITC 54139. As of Q4 2014, RIBOSTAMYCIN remains the US FDA Preferred Term for this commodity. Ribostamycin bears US NLM identifiers UMLS ID C0035554 and NCI Concept Code C90639. SMILES: O(C1C(OC2OC(C(O)C2O)CO)C(O)C(N)CC1N)C1OC(C(O)C(O)C1N)CN.

